Roche Venture Fund

Roche Venture Fund accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $5.2B. The median disclosed raise is $114M, and the largest is Vaxcyte at $2.4B, ahead of Endeavor BioMedicines ($292M) and Arch Oncology ($241M).

The names that recur most often on these co-invested cap tables are Roche Venture Fund (24 companies), 5AM Ventures (5 companies), Sofinnova Partners (4 companies), Versant Ventures (3 companies), Novo Holdings (3 companies), Ysios Capital (3 companies). By latest disclosed round, the market skews Series A (12), Series B (6), Series C (3), IPO (1).

• Companies tracked: 24
• Disclosed funding total: $5.2B across 24 companies
• Median disclosed raise: $114M
• Largest raise: Vaxcyte — $2.4B
• Stage mix: Series A 12 · Series B 6 · Series C 3 · IPO 1
• Most recent dated round: 2026-05-18

Best funded Roche Venture Fund companies

1. Vaxcyte — $2.4B (latest: IPO)
2. Endeavor BioMedicines — $292M (latest: Series A)
3. Arch Oncology — $241M (latest: Series C)
4. Entrada Therapeutics — $241M (latest: Series A)
5. Aligos Therapeutics — $225M (latest: Series B)
6. Epic Sciences — $196M
7. Black Diamond Therapeutics — $194M (latest: Series C)
8. GlycoEra — $179M (latest: Series B)
9. Splice Bio — $170M (latest: Series B)
10. Minoryx Therapeutics — $138M (latest: Series C)
11. Cour Pharmaceuticals Development — $135M (latest: Series A)
12. MISSION Therapeutics — $114M (latest: Series A)
13. IDEAYA Biosciences — $94M (latest: Series B)
14. Bonum Therapeutics — $93M (latest: Series A)
15. NMD Pharma — $79M (latest: Series B)

Roche Venture Fund — related firms and companies (56)

• Vaxcyte
• Endeavor BioMedicines
• Arch Oncology
• Entrada Therapeutics
• Aligos Therapeutics
• Epic Sciences
• Black Diamond Therapeutics
• GlycoEra
• Investors like Wellington Management
• Investors like Andreessen Horowitz
• Investors like Script Capital
• Investors like Venrock
• Investors like First Round Capital
• Investors like Lightbank
• Investors like ARCH Venture Partners
• Investors like Bain Capital Ventures
• Investors like Canapi Ventures
• Investors like Techstars Ventures
• Roche Venture Fund portfolio companies 2026
• DiogenX
• Mironid
• Zikani Therapeutics
• IDEAYA Biosciences
• Minoryx Therapeutics
• Investors like Khosla Ventures
• Investors like boldstart ventures
• Investors like Scale Venture Partners
• Investors like Battery Ventures
• Investors like Ridge Ventures
• Investors like FirstMark
• Investors like Correlation Ventures
• Investors like Oak HC/FT
• Investors like Storm Ventures
• Investors like Headline
• Investors like Founders Fund
• Investors like Roche Venture Fund
• Enthera
• Soteria Biotherapeutics
• Pandion Therapeutics
• Bonum Therapeutics
• Cour Pharmaceuticals Development
• Investors like International Finance Corporation
• Investors like CRV
• Investors like Ventioneers
• Investors like Digital Currency Group
• Investors like Upfront Ventures
• Investors like Zetta Venture Partners
• Investors like Motivate Venture Capital
• Investors like Meritech Capital Partners
• Investors like Kleiner Perkins
• Investors like StepStone Group
• Investors like Lux Capital
• Companies backed by Roche Venture Fund
• Purigen Biosystems
• Vivet Therapeutics
• Aileron Therapeutics

Roche Venture Fund alternatives · All research reports